Trials / Completed
CompletedNCT01102803
D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
Evaluation of the Effects of Post-Session Administration of D-cycloserine On Exposure Therapy Outcomes
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Southern Methodist University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the utility of post-session administration of D-cycloserine to enhance fear extinction in a sample of people with acrophobia who will be treated with CBT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Individual Cognitive Behavioral Therapy (CBT) | The aim of CBT is to help participants become more comfortable with heights situations. Participants will receive 2 sessions over two weeks of individual CBT. |
| DRUG | D-Cycloserine | D-Cycloserine |
| DRUG | Placebo | Sugar Pill |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2010-04-13
- Last updated
- 2013-02-21
- Results posted
- 2013-02-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01102803. Inclusion in this directory is not an endorsement.